Kuntz Richard 4
4 · DiaMedica Therapeutics Inc. · Filed Jan 3, 2025
Insider Transaction Report
Form 4
Kuntz Richard
Director
Transactions
- Award
Voting Common Shares, no par value per share
2025-01-02$5.34/sh+9,925$53,000→ 24,210 total
Footnotes (2)
- [F1]These shares are issuable upon vesting and settlement of a restricted stock unit award granted under the DiaMedica Therapeutics Inc. Amended and Restated 2019 Omnibus Incentive Plan in lieu of cash retainer fees in the aggregate amount of $53,000. The restricted stock unit award will vest in four nearly equal installments on each of March 31, 2025, June 30, 2025, September 30, 2025 and December 31, 2025.
- [F2]Includes 9,925 shares issuable on vesting of a restricted stock unit award granted under the DiaMedica Therapeutics Inc. Amended and Restated 2019 Omnibus Incentive Plan.